These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35132566)
21. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507 [TBL] [Abstract][Full Text] [Related]
22. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG. Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509 [TBL] [Abstract][Full Text] [Related]
23. TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitment. Montibus B; Cercy J; Bouschet T; Charras A; Maupetit-Méhouas S; Nury D; Gonthier-Guéret C; Chauveau S; Allegre N; Chariau C; Hong CC; Vaillant I; Marques CJ; Court F; Arnaud P Cell Mol Life Sci; 2021 Jan; 78(2):757-768. PubMed ID: 32405722 [TBL] [Abstract][Full Text] [Related]
24. KDM6B epigenetically regulates odontogenic differentiation of dental mesenchymal stem cells. Xu J; Yu B; Hong C; Wang CY Int J Oral Sci; 2013 Dec; 5(4):200-5. PubMed ID: 24158144 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of OLIG2 transcription factor in brain cancer. Tsigelny IF; Kouznetsova VL; Lian N; Kesari S Oncotarget; 2016 Aug; 7(33):53074-53101. PubMed ID: 27447975 [TBL] [Abstract][Full Text] [Related]
26. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma. D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606 [TBL] [Abstract][Full Text] [Related]
27. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility. Lee SW; Park DY; Kim MY; Kang C Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835 [TBL] [Abstract][Full Text] [Related]
28. The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival. Wijayatunge R; Chen LF; Cha YM; Zannas AS; Frank CL; West AE Mol Cell Neurosci; 2014 Jul; 61():187-200. PubMed ID: 24983519 [TBL] [Abstract][Full Text] [Related]
29. KDM6B Counteracts EZH2-Mediated Suppression of Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells. Liu OH; Kiema M; Beter M; Ylä-Herttuala S; Laakkonen JP; Kaikkonen MU Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2665-2677. PubMed ID: 32938217 [TBL] [Abstract][Full Text] [Related]
31. KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression. Liu F; Wang Y; Yang Z; Cui X; Zheng L; Fu Y; Shao W; Zhang L; Yang Q; Jia J Cell Death Dis; 2022 Dec; 13(12):1068. PubMed ID: 36564369 [TBL] [Abstract][Full Text] [Related]
32. KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis. Guo T; Han X; He J; Feng J; Jing J; Janečková E; Lei J; Ho TV; Xu J; Chai Y Elife; 2022 Feb; 11():. PubMed ID: 35212626 [TBL] [Abstract][Full Text] [Related]
34. KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development. Shpargel KB; Starmer J; Yee D; Pohlers M; Magnuson T PLoS Genet; 2014 Aug; 10(8):e1004507. PubMed ID: 25101834 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs. Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770 [TBL] [Abstract][Full Text] [Related]
36. KDM6B (JMJD3) and its dual role in cancer. Lagunas-Rangel FA Biochimie; 2021 May; 184():63-71. PubMed ID: 33581195 [TBL] [Abstract][Full Text] [Related]
38. Kdm6b regulates cartilage development and homeostasis through anabolic metabolism. Dai J; Yu D; Wang Y; Chen Y; Sun H; Zhang X; Zhu S; Pan Z; Heng BC; Zhang S; Ouyang H Ann Rheum Dis; 2017 Jul; 76(7):1295-1303. PubMed ID: 28314754 [TBL] [Abstract][Full Text] [Related]
39. Genetic variants in the KDM6B gene are associated with neurodevelopmental delays and dysmorphic features. Stolerman ES; Francisco E; Stallworth JL; Jones JR; Monaghan KG; Keller-Ramey J; Person R; Wentzensen IM; McWalter K; Keren B; Heron B; Nava C; Heron D; Kim K; Burton B; Al-Musafri F; O'Grady L; Sahai I; Escobar LF; Meuwissen M; Reyniers E; Kooy F; Lacassie Y; Gunay-Aygun M; Schatz KS; Hochstenbach R; Zwijnenburg PJG; Waisfisz Q; van Slegtenhorst M; Mancini GMS; Louie RJ Am J Med Genet A; 2019 Jul; 179(7):1276-1286. PubMed ID: 31124279 [TBL] [Abstract][Full Text] [Related]
40. KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma. Manente AG; Pinton G; Zonca S; Tavian D; Habib T; Jithesh PV; Fennell D; Nilsson S; Moro L Epigenomics; 2016 Sep; 8(9):1227-38. PubMed ID: 27529370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]